These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17376429)

  • 1. Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders.
    Pogocki D; Ruman T; Danilczuk M; Danilczuk M; Celuch M; Wałajtys-Rode E
    Eur J Pharmacol; 2007 Jun; 563(1-3):18-39. PubMed ID: 17376429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine and brain disorders.
    Mihailescu S; Drucker-Colín R
    Acta Pharmacol Sin; 2000 Feb; 21(2):97-104. PubMed ID: 11263271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors.
    Hogg RC; Bertrand D
    Biochem Pharmacol; 2007 Feb; 73(4):459-68. PubMed ID: 16979139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders.
    Balfour DJ; Fagerström KO
    Pharmacol Ther; 1996; 72(1):51-81. PubMed ID: 8981571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
    Court JA; Piggott MA; Lloyd S; Cookson N; Ballard CG; McKeith IG; Perry RH; Perry EK
    Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropsychopharmacological profile of nicotine].
    Ando K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):55-9. PubMed ID: 15164610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinic acetylcholine receptor system and neuropsychiatric disorders.
    Singh A; Potter A; Newhouse P
    IDrugs; 2004 Dec; 7(12):1096-103. PubMed ID: 15599803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cellular mechanisms of action of nicotine in the CNS.
    Barik J; Wonnacott S
    Handb Exp Pharmacol; 2009; (192):173-207. PubMed ID: 19184650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinic receptor modulation for neuroprotection and enhancement of functional recovery following brain injury or disease.
    Pauly JR; Charriez CM; Guseva MV; Scheff SW
    Ann N Y Acad Sci; 2004 Dec; 1035():316-34. PubMed ID: 15681815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and biochemical effects of nicotine for primary care providers.
    Metz CN; Gregersen PK; Malhotra AK
    Med Clin North Am; 2004 Nov; 88(6):1399-413, ix. PubMed ID: 15464104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases.
    Egleton RD; Brown KC; Dasgupta P
    Pharmacol Ther; 2009 Feb; 121(2):205-23. PubMed ID: 19063919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic acetylcholine receptors as drug targets.
    Hogg RC; Bertrand D
    Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):123-30. PubMed ID: 15078187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does nicotine have beneficial effects in the treatment of certain diseases?
    Birtwistle J; Hall K
    Br J Nurs; 1996 Oct 24-Nov 13; 5(19):1195-202. PubMed ID: 9006184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.
    Newhouse PA; Potter A; Levin ED
    Drugs Aging; 1997 Sep; 11(3):206-28. PubMed ID: 9303280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco particulate matter is more potent than nicotine at upregulating nicotinic receptors on SH-SY5Y cells.
    Ambrose V; Miller JH; Dickson SJ; Hampton S; Truman P; Lea RA; Fowles J
    Nicotine Tob Res; 2007 Aug; 9(8):793-9. PubMed ID: 17654292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic systems in central nervous systems disease: degenerative disorders and beyond.
    Newhouse PA; Kelton M
    Pharm Acta Helv; 2000 Mar; 74(2-3):91-101. PubMed ID: 10812945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine and nicotinic receptors; relevance to Parkinson's disease.
    Quik M; Kulak JM
    Neurotoxicology; 2002 Oct; 23(4-5):581-94. PubMed ID: 12428730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine an efficient tool of the neurobiological research today, the tool of treatment tomorrow?
    Riljak V; Langmeier M
    Prague Med Rep; 2005; 106(4):329-48. PubMed ID: 16572927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine psychopharmacology: policy and regulatory.
    Henningfield JE; Zeller M
    Handb Exp Pharmacol; 2009; (192):511-34. PubMed ID: 19184661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.